SCM Biogroup-LCD

Deals

CCYSZE(M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
EUR800.0007Feb-28Sr. SecuredB2B-B+FixedBMid to high 3% s3.25-3.5%4093.38%-100.00000
EUR250.0008Feb-29Sr. SecuredCaa1CCC+CCCFixedBMid 5% s5-5.25%5675%-100.00000
Tranche Comments
7 yr: Redemption: 2024-02-01; Registration: 144A/Reg S; Comments: EUR750m 7NC3yr (50/25/par) snr sec RegS/144A, via CAB. With 250m 8NC3 snrB2/B-/B+. GCs JPM(B&D)/BNPP/Natx, JBs Citi/CA-CIB/GS/HSBC. IPTs Mid/High 3%s, talk 3.25%/3.5% , came 800m at 3.375%. B+409 vs 0.5% 2/28. MWC B+50; 8 yr: Redemption: 2024-02-01; Registration: 144A/Reg S; Comments: EUR250m 8NC3yr (50/25/par) snr RegS/144A, via Laboratoire Eimer. With 750m 7NC3 SSN. Caa1/CCC/CCC+. GCs JPM(B&D)/BNPP/Natx, JBs Citi/CA-CIB/GS/HSBC. IPTs Mid 5%s, talk 5%/5.25%, came 5%, B+567 vs 0.25% 2/29. MWC B+50.;
Use of Proceeds
Repay debt and pay fees and expenses

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research